Antitumor activity of ionic liquids on human tumor cell lines

ACS Symposium Series

Volumn 1038, Issue , 2010, Pages 91-102

  Kumar, Vineet ^a   Malhotra, Sanjay V ^a  

^a SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CYTOTOXICITY; MEDICAL APPLICATIONS;

ANTI-TUMOR ACTIVITIES; ANTICANCER ACTIVITIES; BIOMEDICAL APPLICATIONS; HUMAN TUMOR CELL LINES; NATIONAL CANCER INSTITUTE; PHYSIO-CHEMICAL PROPERTIES; STRUCTURE-ACTIVITY RELATIONSHIPS; THERAPEUTIC APPLICATION;

IONIC LIQUIDS;

EID: 84859884544     PISSN: 00976156     EISSN: 19475918     Source Type: Book Series    
DOI: 10.1021/bk-2010-1038.ch008     Document Type: Conference Paper

References (27)

1. (a) Plaquevent, J.-C; Levillain, J.; Guillen, K; Malhiac, C; Gaumont, A.-C. Chem. Rev. 2008, 108, 5035.
2. (b) Dominguez de Maria, P. Angew. Chem., Int. Ed. 2008, 47, 6960.
3. (c) Martins, M. A. P.; Frizzo, C. P.; Moreira, D. N.; Zanatta, N.; Bonacorso, H. G. Chem. Rev. 2008, 108, 2015.
4. (d) Kumar, V; Olsen, C. E.; Schaffer, S. J. C; Parmar, V. S.; Malhotra, S. V Org. Lett. 2007, 9, 3905.
5. (e) Malhotra, S. V; Kumar, V; Parmar, V. S. Curr. Org. Synth. 2007, 4, 370.
6. (f) Zhao, H.; Malhotra, S. V. Aldrichimica Acta 2002, 35, 75.
7. (g) Wasserscheid, W.; Keim, W. Angew. Chem. 2000, 39, 3772.
8. (a) Ranke, J.; Stolte, S.; Stormann, R.; Arning, J.; Jastorff, B. Chem. Rev. 2007, 107, 2183.
9. (b) Stepnowski, P.; Skladanowski, A. C; Ludwiczak, A.; Laczynska, E. Hum. Exper Toxicol. 2004, 23, 513.
10. (c) Frade, R. F. M.; Matias, A.; Branco, L. C; Afonso, C. A. M.; Duarte, C. M. M. Green Chem. 2007, 9, 873.
11. (d) Wang, X.; Ohlin, C. A.; Lu, Q.; Fei, Z.; Hu, J.; Dyson, P. J. Green Chem. 2007, 9, 1191.
12. (e) Ranke, J.; Muller, A.; Bottin-Weber, U.; Stock, F; Stolte, S.; Arning, J.; Stormann, R.; Jastorff, B. Ecotoxicol. Env. Saf 2007, 67, 430.
13. Paracelsus. http://en.wikipedia.org/wiki/Paracelsus (accessed April 28, 2009).
14. Ross, I. A. Medicinal Plants of the World; 2005; Vol. 3, Preface.
15. (a) Anticancer Drug Toxicity: Prevention, Management, and Clinical Pharmacokinetics, 1st ed.; Lipp, H.-P, Ed.; Informa HealthCare: London, 2009.
16. (b) Chemistry and Pharmacology of Anticancer Drugs, 1st ed.; Thurston, D. E., Ed.; CRS Press, Taylor & Francis Group: Boca Raton, FL, 2006.
17. Handbook of Pharmaceutical Salts: Properties, Selection, and Use; Wermuth, C. G., Stahl, P. H., Eds.; Wiley-VCH: Weinheim, Germany, 2002; pi.
18. Pfannkuch, E; Rettig, H.; Stahl, P. H. In Handbook of Pharmaceutical Salts: Properties, Selection, and Use; Wermuth, C. G., Stahl, P. H., Eds.; Wiley-VCH: Weinheim, Germany, 2002; p 130.
19. (a) Hough, W. L.; Smiglak, M.; Rodriguez, H.; Swatloski, R. P.; Spear, S. K.; Daly, D. T; Pernak, J.; Grisel, J. E.; Carliss, R. D.; Soutullo, M. D.; Davis, J. H., Jr.; Rogers, R. D. New J. Chem. 2007, 31, 1429.
20. (b) Hough, W. L.; Rogers, R. D. Bull. Chem. Soc. Jpn. 2007, 80, 2262.
21. Liu, Q.; Janssen, M. H. A.; Van Rantwijk, F; Sheldon, R. A. Green Chem. 2005, 7, 39.
22. (a) Alley, M. C; Scudiero, D. A.; Monks, P. A.; Hursey, M. L.; Czerwinski, M. J.; Fine, D. L.; Abbott, B. J.; Mayo, J. G.; Shoemaker, R. H.; Boyd, M. R. Cancer Res. 1988, 48, 589.
23. (b) Boyd, M. R.; Paull, K. D. DrugDev. Res. 1995, 34, 91.
24. (c) Shoemaker, R. H. Nature Rev. 2006, 6, 813.
25. (a) Decker, S.; Hollingshead, M.; Bonomi, C. A.; Certer, J. P.; Sausville, E. A. Eur. J. Cancer 2004, 40, 821.
26. (b) Hollingshead, M. D.; Alley, M. C; Camalier, R. E; Abott, B. J.; Mayo, J. G.; Malspeir, L.; Grever, M. R. Life Sci. 1995, 57, 131.
27. Kumar, V; Malhotra, S. V Bioorg. Med. Chem. Lett. 2009, 19(16), 4643.